- 全部删除
您的购物车当前为空
Ubrogepant (MK-1602) 是新型的、口服有效的降钙素基因相关肽受体拮抗剂。Ubrogepant 有潜力用于急性偏头痛的相关研究。


为众多的药物研发团队赋能,
让新药发现更简单!
Ubrogepant (MK-1602) 是新型的、口服有效的降钙素基因相关肽受体拮抗剂。Ubrogepant 有潜力用于急性偏头痛的相关研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,330 | In stock | |
| 5 mg | ¥ 3,320 | In stock | |
| 10 mg | ¥ 4,750 | In stock | |
| 25 mg | ¥ 7,290 | In stock | |
| 50 mg | ¥ 9,820 | In stock | |
| 100 mg | ¥ 13,200 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 3,920 | In stock |
Ubrogepant 相关产品
| 产品描述 | Ubrogepant (MK-1602) is an antagonist of calcitonin gene-related peptide receptor that can be used in the acute treatment of migraine studies. |
| 分子量 | 549.54 |
| 分子式 | C29H26F3N5O3 |
| CAS No. | 1374248-77-7 |
| Smiles | C[C@@H]1[C@@H](C[C@H](NC(=O)c2cnc3C[C@]4(Cc3c2)C(=O)Nc2ncccc42)C(=O)N1CC(F)(F)F)c1ccccc1 |
| 密度 | 1.45 g/cm3 (Predicted) |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 245 mg/mL (445.83 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容